Rutaecarpine, Indoloquinazoline alkaloid

Be the first to review this product! 리뷰 제출

|

(0 출판물)

MW 287.3 Da, Purity >99%. Indoloquinazoline alkaloid derived from Evodia rutaecarpa. Various pharmacological actions in vitro and in vivo; anti-inflammatory, antinociceptive, vasorelaxant, antiplatelet aggregation. Pharmacologically active following oral administration.

대체 명칭 보기

2410064E05Rik, AHH, AI195561, ALBU_HUMAN, ANP-A, ANPRA_HUMAN, AR JP, ARNT-interacting protein, Albumin (32 AA), Albumin (AA 34), Aryl hydrocarbon hydroxylase, Atrial natriuretic peptide A type receptor, Atrial natriuretic peptide receptor 1, Atrial natriuretic peptide receptor A, Atrial natriuretic peptide receptor type A, Atrionatriuretic peptide receptor A, BCD541, Basic-helix-loop-helix-PAS protein MOP1, C-mpl ligand, CP 12, CP11, CP1A1_HUMAN, CP1A2_HUMAN, CP1B, CP1B1_HUMAN, CYP 1, CYP1A2, CYPIA1, CYPIA2, CYPIB1, Capsaicin receptor, Class E basic helix-loop-helix protein 78, Component of gems 1, Cyclooxygenase, Cyclooxygenase 2b, Cyclooxygenase 3, included, Cyclooxygenase-1, Cyclooxygenase-2, Cytochrome P(3)450, Cytochrome P1 450 dioxin inducible, Cytochrome P1-450, Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 1B1, Cytochrome P450 4, Cytochrome P450 family 1 polypeptide 2, Cytochrome P450 family 1 subfamily A polypeptide 1, Cytochrome P450 family 1 subfamily A polypeptide 2, Cytochrome P450 family 1 subfamily B polypeptide 1, Cytochrome P450 form 6, Cytochrome P450 subfamily I (aromatic compound inducible) polypeptide 1, Cytochrome P450 subfamily I (dioxin inducible) polypeptide 1 (glaucoma 3 primary infantile), Cytochrome P450 subfamily I aromatic compound inducible polypeptide 2, Cytochrome P450-C, Cytochrome P450-P1, Cytochrome P450-P3, DKFZp434K0220, DKFZp779N1935, Dioxin inducable P3 450, DmRab9, E3 ubiquitin ligase, E3 ubiquitin-protein ligase parkin, EC 1.14.99.1, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ESRL 1, ESRR A, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen-related receptor alpha, Estrra, FRA6E, GC-A, GIG20, GIG42, GLC3A, GRIPGHS, GUCY2A, Gemin-1, Glucocorticoid-regulated inflammatory Prostaglandin G/H synthase, Glucocorticoid-regulated inflammatory cyclooxygenase, Guanylate cyclase, Guanylate cyclase A, HIF-1, HIF-1-alpha, HIF-alpha, HIF1A_HUMAN, Hypoxia inducible factor 1 alpha isoform I.3, Hypoxia inducible factor 1 alpha subunit, Hypoxia inducible factor 1 alpha subunit basic helix loop helix transcription factor, Hypoxia inducible factor 1, alpha subunit (basic helix loop helix transcription factor), Hypoxia-inducible factor 1-alpha, LPRS 2, MGDF, MKCSF, MOP 1, MPL ligand, MPLLG, Macrophage activation-associated marker protein P71/73, Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, Megakaryocyte stimulating factor, Member of PAS protein 1, Member of PAS superfamily 1, Member of the PAS Superfamily 1, Microsomal monooxygenase, Myeloproliferative leukemia virus oncogene ligand, NPC, NPC1_HUMAN, NPR-A, NPR1, NR3B1, Natriuretic Peptide Receptor A, Natriuretic peptide A type receptor, Natriuretic peptide receptor A/guanylate cyclase A, Niemann Pick C1 protein precursor, Niemann Pick disease, type C1, Niemann-Pick C1 protein, Nuclear receptor subfamily 3 group B member 1, OTRPC1, OTTHUMP00000033524, OTTHUMP00000125198, OTTHUMP00000220436, OTTHUMP00000220438, OTTHUMP00000220439, OTTHUMP00000223567, OTTHUMP00000223568, OTTHUMP00000224066, OTTHUMP00000226924, Osm-9-like TRP channel 1, P(3)450, P1 450, P3 450, P450 4, P450 C, P450 P1, P450 P3, P450 form 4, P450 form 6, P450(PA), P4501B1, P450DX, PARK 2, PAS domain-containing protein 8, PASD 8, PCOX1, PDJ, PES-2, PGG/HS, PGH synthase 1, PGH synthase 2, PGH1_HUMAN, PGH2_HUMAN, PGHS-1, PGHS-2, PHS 1, PHS 2, PHS II, PRKN 2, PRKN2_HUMAN, PRO0883, PRO0903, PRO1341, PRO1708, PRO2044, PRO2619, PRO2675, PTGHS, PTGS1, PTGS2, Parkin 2, Parkinson disease (autosomal recessive juvenile) 2, Parkinson disease (autosomal recessive, juvenile) 2, parkin, Parkinson disease protein 2, Parkinson juvenile disease protein 2, Parkinson protein 2 E3 ubiquitin protein ligase, Parkinson protein 2, E3 ubiquitin protein ligase (parkin), Partial COX1 proteins, included, Prostaglandin G/H synthase, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Prostaglandin G/H synthase 2 precursor, Prostaglandin G/H synthase and cyclooxygenase, Prostaglandin H2 synthase 1, Prostaglandin H2 synthase 2, Prostaglandin-endoperoxide synthase 1, Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase), Prostaglandin-endoperoxide synthase 2, RAB9 member RAS oncogene family, RAB9A member RAS oncogene family, RAB9A_HUMAN, RAS ASSOCIATED PROTEIN RAB9, Rab 9, Ras-related protein Rab-9A, SMA, SMA 1, SMA 2, SMA 3, SMA 4, SMN1, SMN2, SMNT, SMN_HUMAN, Sid6061p, Sid99, Steroid hormone receptor ERR1, Survival motor neuron protein, Survival of motor neuron 1, telomeric, T-BCD541, THCYT1, TIS10, TIS10 protein, TRPV1_HUMAN, Thrombopoietin, Thrombopoietin nirs variant 1, Transient receptor potential cation channel subfamily V member 1, UNQ696/PRO1341, Ubiquitin E3 ligase PRKN, VR 1, Vanilloid receptor 1, Vanilloid receptor subtype 1, Xenobiotic monooxygenase, bHLHe78, cell growth inhibiting protein 42, estrogen receptor related receptor alpha, fj02a10, flavoprotein-linked monooxygenase, growth-inhibiting protein 20, hCox 2, hERR1, hifla, prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), ptgs2a, unp1239, wu:fj02a10